Weight
Window of opportunity for arthritis patients being missed due to delays in NHS treatment, says new report
According to a new report carried out by the British Society for Rheumatology (BSR), up to a million Britons are at risk of preventable, long-term disability and reduced life expectancy due to delays in referrals to specialist advice and treatment services. Continue reading
Immunotherapy reduces cardiovascular risk in people with rheumatoid arthritis, says study
A new study suggests that immunotherapy reduces cardiovascular risk in patients with rheumatoid arthritis and that the combination of two extra-low dose anti-cytokine drugs reduces rheumatoid arthritis disease activity and cardiovascular events. Continue reading
Running better than cycling for your bones, suggest study
A new study suggests that running is better for bone health than cycling. Previous Italian research had found that endurance cyclists taking part in the Giro I’Italia experience chronic bone resorption – which means that vital calcium from bones gets released into the blood stream, causing bones to weaken. The same research time wanted to know if there was a similar effect in mountain ultra-marathon runners. Continue reading
New stem cell research could revolutionise treatment for hip replacements
New cutting-edge research has been used to develop and create a new ‘living hip replacement’ that could potentially revolutionise the treatment of arthritis and other joint conditions.
Scientists from the Washington University School of Medicine and Cytex Therapeutics collaborated to find a way to grow new cartilage tissue using stem cells, while also giving the material anti-inflammatory molecules to fight of arthritis. It is said that this could mark a significant advance compared to current hip replacement treatment. Continue reading
New treatment approved in US for treatment of arthritis at the base of the big toe
Cartiva, Inc in US has announced that the first patient has received the Cartiva Synthetic Cartilage Implant (SCI) following its approval by the US Food and Drug Administration (FDA). The new SCI device is intended for the treatment of painful osteoarthritis of the first metatarsophalangeal (MTP) joint, the most common site for osteoarthritis in the forefoot. This is the first synthetic cartilage device approved by the FDA. Continue reading
